Biofidelity Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$24.3M
- Investors
-
10
Biofidelity General Information
Description
Developer of a novel molecular assay designed to broaden access to precision testing for all patients. The company's technology can detect a single molecule of mutated DNA against the background of a large number of healthy molecules present in a typical patient sample and can be implemented on existing laboratory instrumentation with a simple workflow and sensitivity, enabling oncologists to target the right treatments at the right time.
Contact Information
Website
www.biofidelity.comCorporate Office
- 330 Cambridge Science Park
- Milton Road
- Cambridge CB4 0WN
- England, United Kingdom
Corporate Office
- 330 Cambridge Science Park
- Milton Road
- Cambridge CB4 0WN
- England, United Kingdom
Biofidelity Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 13-Apr-2024 | $24.3M | Completed | Generating Revenue | ||
| 5. Early Stage VC (Series A1) | 01-Feb-2022 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 20-Aug-2020 | Completed | Generating Revenue | |||
| 3. Grant | 10-Oct-2019 | Completed | Generating Revenue | |||
| 2. Seed Round | 16-May-2019 | $974K | $974K | Completed | Generating Revenue | |
| 1. University Spin-Out | 01-Feb-2019 | Completed | Generating Revenue |
Biofidelity Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-4 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| B Ordinary | ||||||||
| Series A-2 | 2,019,769 | $0.000013 | $5.54 | $5.54 | 2x | $5.54 | 20.24% | |
| Ordinary | 477,707 | $0.000013 | $1.98 | $1.98 | 1x | $1.98 | 4.79% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Biofidelity Comparisons
Industry
Financing
Details
Biofidelity Competitors (4)
One of Biofidelity’s 4 competitors is Biocept, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Biocept | Formerly VC-backed | San Diego, CA | ||||
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| Qiagen | Formerly VC-backed | Hilden, Germany | ||||
| Guardant Health | Formerly VC-backed | Palo Alto, CA |
Biofidelity Patents
Biofidelity Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4605551-A2 | Nucleic acid analysis | Pending | 19-Oct-2022 | ||
| US-20260110021-A1 | Nucleic acid analysis | Pending | 19-Oct-2022 | ||
| WO-2024084439-A2 | Nucleic acid analysis | Inactive | 19-Oct-2022 | ||
| WO-2024084439-A3 | Nucleic acid analysis | Inactive | 19-Oct-2022 | ||
| EP-4605546-A1 | Nucleic acid enrichment and detection | Pending | 19-Oct-2022 | C12Q1/6806 |
Biofidelity Signals
Biofidelity Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Octopus Ventures | Venture Capital | Minority | ||
| Perscitus | Family Office | Minority | ||
| SBI Investment | Venture Capital | Minority | ||
| Agilent Technologies | Corporation | Minority | ||
| BlueYard Capital | Venture Capital | Minority |
Biofidelity FAQs
-
When was Biofidelity founded?
Biofidelity was founded in 2019.
-
Where is Biofidelity headquartered?
Biofidelity is headquartered in Cambridge, United Kingdom.
-
What is the size of Biofidelity?
Biofidelity has 25 total employees.
-
What industry is Biofidelity in?
Biofidelity’s primary industry is Discovery Tools (Healthcare).
-
Is Biofidelity a private or public company?
Biofidelity is a Private company.
-
What is the current valuation of Biofidelity?
The current valuation of Biofidelity is .
-
What is Biofidelity’s current revenue?
The current revenue for Biofidelity is .
-
How much funding has Biofidelity raised over time?
Biofidelity has raised $61.4M.
-
Who are Biofidelity’s investors?
Octopus Ventures, Perscitus, SBI Investment, Agilent Technologies, and BlueYard Capital are 5 of 10 investors who have invested in Biofidelity.
-
Who are Biofidelity’s competitors?
Biocept, Foundation Medicine, Qiagen, and Guardant Health are competitors of Biofidelity.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process